Compare WT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WT | HAE |
|---|---|---|
| Founded | 1985 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2011 | 1996 |
| Metric | WT | HAE |
|---|---|---|
| Price | $18.77 | $77.49 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 9 |
| Target Price | $17.67 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 3.3M | 781.0K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ 127.27 | N/A |
| EPS | N/A | ★ 2.05 |
| Revenue | $493,753,000.00 | ★ $910,373,000.00 |
| Revenue This Year | $35.04 | N/A |
| Revenue Next Year | $8.68 | $5.23 |
| P/E Ratio | ★ N/A | $37.17 |
| Revenue Growth | ★ 15.43 | N/A |
| 52 Week Low | $10.69 | $47.32 |
| 52 Week High | $20.18 | $87.32 |
| Indicator | WT | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 54.49 | 63.44 |
| Support Level | $18.50 | $72.04 |
| Resistance Level | $18.91 | $80.90 |
| Average True Range (ATR) | 0.77 | 2.70 |
| MACD | 0.18 | -0.36 |
| Stochastic Oscillator | 59.60 | 68.79 |
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.